During the study period, 12 patients with K. kingae infections were detected (10 with AS and 2 with OM), all less than 24 months of age, and they comprised the study group. Blood culture was positive in 3 patients, synovial fluid culture in 3, and PCR in 7. No patient with confirmed K. kingae infection required admission. The median delay from disease onset to diagnosis was 4 (range, 0-12) days.
All children with synovitis underwent arthrocentesis and washout before receiving oral treatment (cefuroxime axetil or amoxicillin-clavulanic acid) and were managed through scheduled visits to the hospital. In the first 4 days, even with clinical improvement, some patients had moderate swelling, and arthrocentesis was performed a second time (7 patients, 58%). The mean length of treatment was 23 (range, 21-28) days. All patients completely recovered without sequelae in the one-year follow-up visit.
To our knowledge, this is the first series in children with K. kingae OAI, who were entirely treated with oral antibiotics. In some countries, K. kingae has become the causal agent of OAI in children younger than 4 years, yielding a lower C-reactive protein (CRP) level than other agents and it is also probably a less severe infections (3, 4) . In our series, oral treatment from the start demonstrated complete resolution in 100% of the patients. The early onset of antibiotic therapy, the young age of the patients, and the increased bone vascularization due to infection, particularly in younger children, might explain the good response to exclusively oral treatment. In addition, in antibiotics in which minimal inhibitory concentration is important (as in cephalosporins), slow oral absorption may be as effective as intravenous bolus infusion. (5, 6) .
In spite of our small number of patients in our study, the retrospective design, and the absence of a control group, we suggest that candidates for exclusively oral treatment are patients younger 2 years, in a good general condition, in whom K. kingae is suspected as the causative agent, and who can be closely followed as outpatients. This decision must be taken with caution and supervision (particularly in the first 24-48 h) because if Staphylococcus aureus is suspected, intravenous treatment should be started. Prospective studies are necessary to corroborate this hypothesis. 
